title: New chapter unfolding in the fight against dengue with an unwritten ending.
authors.affiliation: Dengue Vaccine Initiative (DVI) and International Vaccine Institute (IVI), Initiative for Vaccine Research (IVR), SNU Research Park, 1 Gwanak-ro, Gwanak-gu, Seoul, 151-742 Korea Georges.Thiry@IVI.INT.
authors.forename: Georges
authors.initials: G
authors.lastname: Thiry
authors.affiliation: Dengue Vaccine Initiative (DVI) and Initiative for Vaccine Research, World Health Organization (IVR/WHO), 20 Avenue Appia, 1211 Geneva 27, Switzerland.
authors.forename: Joachim
authors.initials: J
authors.lastname: Hombach
authors.affiliation: Dengue Vaccine Initiative (DVI) and IVAC, 855 N Wolfe Street, Suite 600, Baltimore, MD 21205, USA.
authors.forename: Dagna
authors.initials: D
authors.lastname: Constenla
authors.affiliation: Dengue Vaccine Initiative (DVI) and Sabin Vaccine Institute, 2000 Pennsylvania Ave. NW, Suite 7100, Washington, DC 20006, USA.
authors.forename: Ana
authors.initials: A
authors.lastname: Carvalho
authors.affiliation: Dengue Vaccine Initiative (DVI) and IVAC, 855 N Wolfe Street, Suite 600, Baltimore, MD 21205, USA.
authors.forename: Anna
authors.initials: A
authors.lastname: Durbin
mesh_terms: D017326:Clinical Trials, Phase III as Topic; D003715:Dengue / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000627:therapeutic use*; D006801:Humans; D014613:Vaccines, Attenuated / Q000627:therapeutic use
chemical_list: D053059:Dengue Vaccines; D014613:Vaccines, Attenuated